Martin Alexander Krekling

Promon AS develops security software systems for protecting applications and data. It provides system for protecting applications and data against security threats and cyber-crime. It develops and sells its security software on a business-to-business basis such as Banks, Payment Service providers, Health Care providers, Hi-tech Industry, Public Sector, and organizations. The firm's product includes Promon Shield, which provides dedicated Trojan protection on the end point which is integrated in the actual service to be secured; and the Promon SDK module provides Promon Shield protection as plugin for existing applications or mobile apps. The company was founded by Tom Lysemose Hansen in January 11, 2006 and is headquartered in Oslo, Norway.

Kistefos AS (Private Equity) is a venture capital firm located in Oslo, Norway. Established in 1995, Kistefos AS (Private Equity) is a wholly-owned subsidiary of Kistefos AS, owned by Christen Sveaas. The parent firm can trace their history to 1889 when the Sveaas founded their factory, A/S Kistefos Træsliberi, near the namesake Kistefossen waterfalls south of Jevnaker, Norway. Kistefos AS (Private Equity) specializes in early-stage investments in several focus areas such as technology, telecommunications and financial services.

Advanzia Bank SA engages in the provision of banking and financial services. It specializes in credit cards and payment solutions. The company was founded by Tor Erland Fyksen in 2005 and is headquartered in Luxembourg.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway.

NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway.

Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials.

ProfMOF AS manufactures metal organic frameworks. The company was founded by Sachin Maruti Chavan, Unni Olsbye, Karl Petter Lillerud and Norbert Stock in 2015 and is headquartered in Kongsberg, Norway.

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.

Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway.

Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway.

Orphan Diagnostics AS engaged in the provision of focusing on point-of-care diagnostics in clinical toxicology. The company was founded in 2016 and is headquartered in Oslo, Norway.

Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway.

Lightpoint Medical Ltd. develops imaging technology for cancer surgery. It has developed a groundbreaking surgical imaging technology based on Cerenkov Luminescence Imaging(CLI). The firm's CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the need for repeat operations. The company was founded by David Tuch in 2012 and is headquartered in Chesham, the United Kingdom.